Scientists harness Patients' own immune cells to attack Treatment-Resistant melanoma
Disease control
Not yet recruiting
This study tests a therapy called Perkileucel, made from a patient's own immune cells (tumor-infiltrating lymphocytes). These cells are collected from a surgically removed melanoma tumor, grown in a lab, and then infused back into the patient. Before the infusion, patients receiv…
Phase: PHASE2 • Sponsor: East Metropolitan Health Service, Australia • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC